Literature DB >> 18034274

Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor.

Yasushi Sakata1, Amanda L Chancey, Vijay G Divakaran, Kenichi Sekiguchi, Natarajan Sivasubramanian, Douglas L Mann.   

Abstract

The mechanisms that are responsible for the development of myocardial fibrosis in inflammatory cardiomyopathy are unknown. We have previously generated lines of transgenic mice with cardiac-restricted overexpression of tumor necrosis factor (MHCsTNF mice), a pro-inflammatory cytokine. The MHCsTNF mice develop a heart failure phenotype that is characterized by progressive myocardial fibrosis, as well as increased levels transforming growth factor-beta (TGF-beta)(mRNA and protein. In order to determine whether TGF-beta-mediated signaling was responsible for the myocardial fibrosis observed in the MHCsTNF mice, we treated MHCsTNF and littermate control mice from 4 to 12 weeks of age with a novel orally available TGF-beta receptor antagonist (NP-40208). At the time of terminal study, myocardial collagen content was determined using the picrosirius red technique, and left ventricular (LV) systolic and diastolic function were determined using the Langendorff method. Treatment with NP-40208 resulted in a significant (P < 0.05) 65% decrease in nuclear translocation of Smad 2/3, a significant (P < 0.05), decrease in the heart-weight to body-weight ratio from 6.5 to 5.7, a approximately 37% decrease in fibrillar collagen content (P < 0.01) and a significant (P < 0.05) decrease in the LV chamber stiffness by approximately 25% in the MHCsTNF mice when compared to diluent-treated controls. Treatment with NP-40208 had no discernable effect on LV systolic function, nor any effect on cardiac myocyte size or fetal gene expression in the MHCsTNF mice. Taken together, these observations suggest that sustained pro-inflammatory signaling in the adult heart is associated with a pro-fibrotic phenotype that arises, at least in part, from TGF-beta-mediated signaling, with resultant activation of Smad 2/3, leading to increased myocardial fibrosis and increased LV diastolic chamber stiffness.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18034274      PMCID: PMC3872069          DOI: 10.1007/s00395-007-0689-5

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  35 in total

Review 1.  Transcriptional control by the TGF-beta/Smad signaling system.

Authors:  J Massagué; D Wotton
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

2.  Functional significance of hemodynamic overload-induced expression of leukemia-inhibitory factor in the adult mammalian heart.

Authors:  F Wang; Y Seta; G Baumgarten; D J Engel; N Sivasubramanian; D L Mann
Journal:  Circulation       Date:  2001-03-06       Impact factor: 29.690

Review 3.  Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling.

Authors:  Y Y Li; C F McTiernan; A M Feldman
Journal:  Cardiovasc Res       Date:  2000-05       Impact factor: 10.787

4.  Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin.

Authors:  N A Trueblood; Z Xie; C Communal; F Sam; S Ngoy; L Liaw; A W Jenkins; J Wang; D B Sawyer; O H Bing; C S Apstein; W S Colucci; K Singh
Journal:  Circ Res       Date:  2001-05-25       Impact factor: 17.367

Review 5.  Induction of cardiac fibrosis by transforming growth factor-beta(1).

Authors:  P J Lijnen; V V Petrov; R H Fagard
Journal:  Mol Genet Metab       Date:  2000 Sep-Oct       Impact factor: 4.797

6.  Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy.

Authors:  Y Y Li; Y Q Feng; T Kadokami; C F McTiernan; R Draviam; S C Watkins; A M Feldman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

7.  Cardiac-specific overexpression of tumor necrosis factor-alpha causes oxidative stress and contractile dysfunction in mouse diaphragm.

Authors:  X Li; M R Moody; D Engel; S Walker; F J Clubb; N Sivasubramanian; D L Mann; M B Reid
Journal:  Circulation       Date:  2000-10-03       Impact factor: 29.690

8.  Transforming growth factor-beta 1-induced activation of the ERK pathway/activator protein-1 in human lung fibroblasts requires the autocrine induction of basic fibroblast growth factor.

Authors:  G A Finlay; V J Thannickal; B L Fanburg; K E Paulson
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

9.  Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro.

Authors:  D A Siwik; D L Chang; W S Colucci
Journal:  Circ Res       Date:  2000-06-23       Impact factor: 17.367

10.  Regulation of proangiogenic factor CCN1 in cardiac muscle: impact of ischemia, pressure overload, and neurohumoral activation.

Authors:  Denise Hilfiker-Kleiner; Karol Kaminski; Agnieszka Kaminska; Martin Fuchs; Gunnar Klein; Edith Podewski; Karsten Grote; Ioulia Kiian; Kai C Wollert; Andres Hilfiker; Helmut Drexler
Journal:  Circulation       Date:  2004-04-26       Impact factor: 29.690

View more
  29 in total

Review 1.  Fetal hypoxia and programming of matrix metalloproteinases.

Authors:  Wenni Tong; Lubo Zhang
Journal:  Drug Discov Today       Date:  2011-09-18       Impact factor: 7.851

2.  Immune-inflammatory dysregulation modulates the incidence of progressive fibrosis and diastolic stiffness in the aging heart.

Authors:  Katarzyna A Cieslik; George E Taffet; Signe Carlson; Jesus Hermosillo; Joann Trial; Mark L Entman
Journal:  J Mol Cell Cardiol       Date:  2010-10-23       Impact factor: 5.000

3.  Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy.

Authors:  Sandra B Haudek; Jizhong Cheng; Jie Du; Yanlin Wang; Jesus Hermosillo-Rodriguez; JoAnn Trial; George E Taffet; Mark L Entman
Journal:  J Mol Cell Cardiol       Date:  2010-05-19       Impact factor: 5.000

Review 4.  [Basic mechanisms of the new antiarrhythmic drugs in atrial fibrillation].

Authors:  David Filgueiras-Rama; Sergio Castrejón; Conrado Calvo; Alejandro Estrada; David Doiny; Marta Ortega; Omer Berenfeld; José L Merino; José Jalife
Journal:  Arch Cardiol Mex       Date:  2012 Apr-Jun

Review 5.  Transforming growth factor (TGF)-β signaling in cardiac remodeling.

Authors:  Marcin Dobaczewski; Wei Chen; Nikolaos G Frangogiannis
Journal:  J Mol Cell Cardiol       Date:  2010-11-06       Impact factor: 5.000

6.  Curcumin promotes cardiac repair and ameliorates cardiac dysfunction following myocardial infarction.

Authors:  Ning-Ping Wang; Zhang-Feng Wang; Stephanie Tootle; Tiji Philip; Zhi-Qing Zhao
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

Review 7.  NADPH oxidases and cardiac remodelling.

Authors:  Adam Nabeebaccus; Min Zhang; Ajay M Shah
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

8.  Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload.

Authors:  Norimichi Koitabashi; Thomas Danner; Ari L Zaiman; Yigal M Pinto; Janelle Rowell; Joseph Mankowski; Dou Zhang; Taishi Nakamura; Eiki Takimoto; David A Kass
Journal:  J Clin Invest       Date:  2011-05-02       Impact factor: 14.808

9.  Tumor necrosis factor receptor-associated factor 2 signaling provokes adverse cardiac remodeling in the adult mammalian heart.

Authors:  Vijay G Divakaran; Sarah Evans; Veli K Topkara; Abhinav Diwan; Jana Burchfield; Feng Gao; Jianwen Dong; Huei-Ping Tzeng; Natarajan Sivasubramanian; Philip M Barger; Douglas L Mann
Journal:  Circ Heart Fail       Date:  2013-03-14       Impact factor: 8.790

10.  Inhibition of transforming growth factor-beta signaling induces left ventricular dilation and dysfunction in the pressure-overloaded heart.

Authors:  Jason A Lucas; Yun Zhang; Peng Li; Kaizheng Gong; Andrew P Miller; Erum Hassan; Fadi Hage; Dongqi Xing; Bryan Wells; Suzanne Oparil; Yiu-Fai Chen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-11-20       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.